Eagle Pharmaceuticals/ US2697961082 /
| 5/2/2024 6:32:35 PM | Chg. +0.32 | Volume | Bid- | Ask6:36:35 PM | High | Low |
|---|---|---|---|---|---|---|
| 4.50USD | +7.54% | 1,063 Turnover: 4,739.02 |
-Bid Size: - | 4.53Ask Size: 200 | 4.64 | 4.25 |
GlobeNewswire
4/30
Eagle Pharmaceuticals Announces a Trial in Progress Presentation of Phase 2/3 Study of Intravenous A...
GlobeNewswire
4/15
Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Respon...
GlobeNewswire
4/12
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirem...
GlobeNewswire
2/11
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Eagle Pharmaceu...
GlobeNewswire
2/9
EGRX DEADLINE TOMORROW: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. ...
GlobeNewswire
2/8
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc.(EGRX) Investors of a Class ...
GlobeNewswire
2/8
EAGLE PHARMACEUTICALS 48 HOUR DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (J...
GlobeNewswire
2/8
EGRX FINAL DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Eagle Pharmaceuticals...
GlobeNewswire
2/5
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc.(EGRX) Investors of a Class ...
GlobeNewswire
2/5
DEADLINE ALERT for GM, EGRX, MRCY, and ON: The Law Offices of Frank R. Cruz Reminds Investors of Cla...
GlobeNewswire
2/5
DEADLINE ALERT for EGRX, ON, MRCY, LOVE: Law Offices of Howard G. Smith Reminds Investors of Class A...
GlobeNewswire
2/5
Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on...
GlobeNewswire
2/5
Holzer & Holzer, LLC Reminds Investors of February 9, 2024 Lead Plaintiff Deadline in Eagle Pharmace...
GlobeNewswire
2/5
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Eag...
GlobeNewswire
2/4
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Be...
GlobeNewswire
2/3
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Eagle Pharmaceu...
GlobeNewswire
2/2
ROSEN, A LEADING LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before...
GlobeNewswire
2/1
EAGLE PHARMACEUTICALS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner J...
GlobeNewswire
2/1
Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on...
GlobeNewswire
2/1
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc.(EGRX) Investors of a Class ...
GlobeNewswire
2/1
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Agains...
GlobeNewswire
2/1
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mic...
GlobeNewswire
1/31
DEADLINE ALERT for GM, EGRX, MRCY, and ON: The Law Offices of Frank R. Cruz Reminds Investors of Cla...
